Regulation of alcohol drinking by ventral striatum and extended amygdala circuitry.

Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE

Publication: Oxford : Pergamon Press
Original Publication: Oxford, New York, Pergamon.

Alcohol Drinking* ; Ventral Striatum*/metabolism; Amygdala/metabolism ; Corticotropin-Releasing Hormone/metabolism ; Ethanol ; Humans ; Receptors, Corticotropin-Releasing Hormone

Alcohol use disorder is a complex psychiatric disorder that can be modeled in rodents using a number of drinking paradigms. Drinking-in-the-dark (DID) is widely used to model the binge/intoxication stage of addiction, and chronic intermittent ethanol vapor procedures (CIE) are used to induce dependence and model withdrawal/negative affect induced escalation of drinking. We discuss experiments showing the ventral striatum (vStr) and extended amygdala (EA) are engaged in response to ethanol in rodents through c-Fos/Fos immunoreactivity studies. We also discuss experiments in rodents that span a wide variety of techniques where the function of vStr and EA structures are changed following DID or CIE, and the role of neurotransmitter and neuropeptide systems studies in these ethanol-related outcomes. We note where signaling systems converge across regions and paradigms and where there are still gaps in the literature. Dynorphin/κ-opioid receptor (KOR) signaling, as well as corticotropin releasing factor (CRF)/CRF receptor signaling were found to be important regulators of drinking behaviors across brain regions and drinking paradigms. Future research will require that females and a variety of rodent strains are used in preclinical experiments in order to strengthen the generalizability of findings and improve the likelihood of success for testing potential therapeutics in human laboratory studies.
(Published by Elsevier Ltd.)

Neuropsychopharmacology. 2017 Aug;42(9):1789-1799. (PMID: 28294133)
Neuropharmacology. 2018 Sep 15;140:162-173. (PMID: 30075159)
Brain Behav Immun. 2019 Jan;75:208-219. (PMID: 30791967)
Front Pharmacol. 2015 Mar 19;6:49. (PMID: 25852553)
Science. 1986 Oct 3;234(4772):80-3. (PMID: 3749894)
Neuropsychopharmacology. 2019 May;44(6):1084-1092. (PMID: 30555162)
Alcohol Clin Exp Res. 2019 Aug;43(8):1695-1701. (PMID: 31141179)
Alcohol. 2016 Feb;50:19-25. (PMID: 26775553)
Alcohol Clin Exp Res. 2012 Sep;36(9):1623-33. (PMID: 22432643)
Pharmacol Rev. 2016 Apr;68(2):242-63. (PMID: 26772794)
Biol Sex Differ. 2016 Jul 26;7:34. (PMID: 27468347)
Pharmacol Biochem Behav. 2019 Feb;177:34-60. (PMID: 30590091)
Alcohol Clin Exp Res. 2020 Jun;44(6):1224-1233. (PMID: 32406553)
J Neurosci. 2019 Feb 6;39(6):1030-1043. (PMID: 30530860)
Neuropsychopharmacology. 2010 May;35(6):1241-52. (PMID: 20130533)
Alcohol Clin Exp Res. 2021 May;45(5):1028-1038. (PMID: 33830508)
Neuropsychopharmacology. 2016 Nov;41(12):2818-2829. (PMID: 27109623)
Biol Sex Differ. 2014 Oct 03;5:15. (PMID: 25780556)
Neuropharmacology. 2022 Feb 1;203:108874. (PMID: 34748860)
Alcohol. 2005 Jul;36(3):161-8. (PMID: 16377457)
Neuropsychopharmacology. 2018 Aug;43(9):1840-1850. (PMID: 29748627)
Alcohol Clin Exp Res. 2019 May;43(5):783-790. (PMID: 30817015)
Neuron. 2014 Apr 16;82(2):261-78. (PMID: 24742456)
Alcohol Clin Exp Res. 1997 Nov;21(8):1497-507. (PMID: 9394124)
Genes Brain Behav. 2009 Jul;8(5):493-9. (PMID: 19243450)
Subst Abuse Rehabil. 2014 Aug 08;5:87-94. (PMID: 25187751)
Drug Alcohol Depend. 2015 May 1;150:24-30. (PMID: 25765483)
Addict Biol. 2013 Jan;18(1):121-33. (PMID: 22574861)
Alcohol. 2017 Feb;58:93-106. (PMID: 27838001)
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2271-6. (PMID: 20133871)
Neuropharmacology. 2015 Dec;99:735-49. (PMID: 26188147)
Psychopharmacology (Berl). 2005 Oct;181(4):688-96. (PMID: 16001125)
J Neurosci. 2012 Mar 7;32(10):3405-13. (PMID: 22399763)
J Clin Psychopharmacol. 2001 Feb;21(1):72-7. (PMID: 11199951)
Pharmacol Biochem Behav. 2017 Sep;160:55-62. (PMID: 28827047)
Cell. 2012 Feb 3;148(3):596-607. (PMID: 22304924)
Alcohol Health Res World. 1997;21(2):114-20. (PMID: 15704346)
Neuropharmacology. 2014 Jan;76 Pt B:320-8. (PMID: 23752096)
Neuropsychopharmacology. 2021 Feb;46(3):509-518. (PMID: 33191400)
Brain Sci. 2019 Dec 11;9(12):. (PMID: 31835746)
Alcohol Clin Exp Res. 2019 Oct;43(10):2000-2013. (PMID: 31403699)
Front Neurosci. 2020 Jul 29;14:797. (PMID: 32848568)
World Neurosurg. 2013 Sep-Oct;80(3-4):S28.e21-31. (PMID: 22824557)
J Neurosci. 2013 Feb 20;33(8):3284-98. (PMID: 23426657)
Sci Rep. 2018 Nov 12;8(1):16702. (PMID: 30420682)
J Neurosci. 2004 Nov 10;24(45):10159-66. (PMID: 15537886)
J Neurosci. 2020 Jan 15;40(3):632-647. (PMID: 31744862)
Nat Commun. 2019 Mar 18;10(1):1238. (PMID: 30886240)
Alcohol Clin Exp Res. 1993 Jun;17(3):525-31. (PMID: 8392817)
J Neurophysiol. 2015 Nov;114(5):2903-11. (PMID: 26400259)
Biol Psychiatry. 2015 May 15;77(10):859-69. (PMID: 25433901)
J Comp Neurol. 1990 Dec 22;302(4):697-706. (PMID: 1707064)
Brain Res. 2008 Nov 6;1239:127-40. (PMID: 18789904)
Alcohol Clin Exp Res. 2016 Jun;40(6):1182-91. (PMID: 27154003)
Neuropharmacology. 2006 Apr;50(5):632-9. (PMID: 16406445)
Neuropharmacology. 2006 Oct;51(5):1013-22. (PMID: 16904135)
Neuropharmacology. 2017 Jan;112(Pt A):164-171. (PMID: 26946430)
Physiol Rev. 2007 Oct;87(4):1113-73. (PMID: 17928582)
Alcohol Clin Exp Res. 1998 Nov;22(8):1646-54. (PMID: 9835277)
Mol Cell Neurosci. 2017 Dec;85:93-104. (PMID: 28942046)
J Neurosci. 2012 May 30;32(22):7563-71. (PMID: 22649234)
Neuropharmacology. 2019 Apr;148:210-219. (PMID: 30659838)
J Comp Neurol. 2016 Aug 15;524(12):2379-99. (PMID: 26718312)
Eur J Neurosci. 2018 Dec;48(11):3335-3343. (PMID: 30362199)
Ann N Y Acad Sci. 1999 Jun 29;877:33-48. (PMID: 10415641)
Brain Res. 1995 May 8;679(1):89-98. (PMID: 7648269)
Alcohol Clin Exp Res. 2017 Aug;41(8):1402-1418. (PMID: 28425121)
Brain Res. 2000 Apr 7;861(1):173-7. (PMID: 10751579)
Psychopharmacology (Berl). 2007 Sep;193(4):495-501. (PMID: 17492432)
Front Behav Neurosci. 2019 Jan 15;12:331. (PMID: 30697154)
Psychopharmacology (Berl). 2021 Aug;238(8):2179-2189. (PMID: 33846866)
Neuroscience. 2015 May 7;293:92-108. (PMID: 25727639)
Physiol Behav. 2005 Jan 31;84(1):53-63. (PMID: 15642607)
Synapse. 2006 Nov;60(6):411-9. (PMID: 16881070)
Alcohol Clin Exp Res. 2017 Dec;41(12):1986-1999. (PMID: 28940382)
Alcohol Clin Exp Res. 2001 Nov;25(11):1662-72. (PMID: 11707641)
Brain Sci. 2020 Feb 18;10(2):. (PMID: 32085427)
Neuropsychopharmacology. 2016 Jan;41(1):126-41. (PMID: 26105138)
Brain Sci. 2021 Aug 29;11(9):. (PMID: 34573170)
Curr Med Chem. 2017;24(24):2661-2670. (PMID: 27915987)
Addict Biol. 2020 Mar;25(2):e12715. (PMID: 30648329)
Alcohol Clin Exp Res. 2012 Dec;36(12):2017-27. (PMID: 22577873)
Neuropsychopharmacology. 2022 Mar;47(4):847-856. (PMID: 34837077)
Handb Behav Neurosci. 2020;26:63-100. (PMID: 32792868)
Neuropsychopharmacology. 2010 Jan;35(1):217-38. (PMID: 19710631)
Genes Brain Behav. 2015 Jan;14(1):98-135. (PMID: 25565358)
Psychoneuroendocrinology. 2017 Oct;84:17-31. (PMID: 28647675)
Neuroimage. 2014 May 1;91:311-23. (PMID: 24444996)
Neuropsychopharmacology. 2011 Dec;36(13):2762-73. (PMID: 21881571)
Addiction. 2018 Feb;113(2):220-237. (PMID: 28940866)
Neuroscience. 2005;136(4):1049-71. (PMID: 16226842)
Brain Res. 2007 Jun 25;1155:172-8. (PMID: 17512918)
Pharmacopsychiatry. 2016 Jul;49(4):170-3. (PMID: 27145161)
Biol Psychiatry. 2016 Mar 15;79(6):443-51. (PMID: 25861702)
Handb Clin Neurol. 2014;125:293-311. (PMID: 25307582)
Alcohol Clin Exp Res. 2008 Feb;32(2):197-208. (PMID: 18162080)
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):. (PMID: 31988201)
J Biol Chem. 2007 Nov 9;282(45):33052-63. (PMID: 17875639)
J Neurosci. 2018 Sep 5;38(36):7761-7773. (PMID: 30054393)
Alcohol Clin Exp Res. 2007 Jun;31(6):939-49. (PMID: 17403068)
Biol Psychiatry. 2011 Jun 1;69(11):1091-9. (PMID: 21459365)
Addict Biol. 2020 Nov;25(6):e12804. (PMID: 31288295)
FASEB J. 2017 Jan;31(1):29-34. (PMID: 27682203)
J Neurosci. 2015 Apr 15;35(15):5959-68. (PMID: 25878269)
Alcohol Clin Exp Res. 2019 Oct;43(10):2014-2027. (PMID: 31373708)
Alcohol Clin Exp Res. 2017 Mar;41(3):551-561. (PMID: 28097729)
PLoS One. 2015 Mar 24;10(3):e0121522. (PMID: 25803291)
J Neurosci. 2006 Nov 1;26(44):11324-32. (PMID: 17079660)
Neurosurg Focus. 2018 Aug;45(2):E12. (PMID: 30064314)
Neuropsychopharmacology. 2019 Dec;44(13):2155-2158. (PMID: 31527863)
Prog Neurobiol. 2021 Apr;199:101952. (PMID: 33197496)
Nat Commun. 2021 Apr 8;12(1):2100. (PMID: 33833228)
Neuropsychopharmacology. 2009 Oct;34(11):2420-9. (PMID: 19553918)
Brain Res. 2015 Jan 12;1594:125-35. (PMID: 25452024)
J Consult Clin Psychol. 2018 Sep;86(9):765-774. (PMID: 30138015)
Alcohol Alcohol. 2020 Feb 7;55(1):56-62. (PMID: 31746964)
J Neurosci. 2020 Sep 2;40(36):6842-6853. (PMID: 32769108)
Neuropsychopharmacology. 2012 May;37(6):1409-21. (PMID: 22218088)
Ann N Y Acad Sci. 1999 Jun 29;877:445-60. (PMID: 10415664)
Front Genet. 2018 Sep 10;9:325. (PMID: 30250478)
Pharmacol Biochem Behav. 2004 Dec;79(4):623-32. (PMID: 15582670)
J Neurosci. 2013 Jan 16;33(3):950-60. (PMID: 23325234)
Brain Res. 1997 May 9;756(1-2):278-82. (PMID: 9187343)
Alcohol Clin Exp Res. 2004 Nov;28(11):1676-82. (PMID: 15547454)
Neuropeptides. 2012 Dec;46(6):253-9. (PMID: 22938859)
Mol Psychiatry. 2021 Jun;26(6):2187-2199. (PMID: 32099099)
Pharmacol Biochem Behav. 2007 Apr;86(4):813-21. (PMID: 17482248)
J Comp Neurol. 2010 Apr 15;518(8):1330-48. (PMID: 20151363)
Alcohol Clin Exp Res. 2018 May;42(5):879-888. (PMID: 29668112)
Front Endocrinol (Lausanne). 2013 Mar 06;4:18. (PMID: 23508038)
Psychopharmacology (Berl). 2009 Jan;201(4):569-80. (PMID: 18791704)
Alcohol Clin Exp Res. 2007 Jan;31(1):11-8. (PMID: 17207096)
Neuroscience. 2014 Sep 26;277:184-95. (PMID: 25003712)
Brain Struct Funct. 2017 Jan;222(1):21-39. (PMID: 26908365)
Neuropsychopharmacology. 2016 Jan;41(2):560-7. (PMID: 26105136)
Neuropharmacology. 2020 May 15;168:107759. (PMID: 31494142)
Alcohol Clin Exp Res. 2015 Aug;39(8):1425-33. (PMID: 26108334)
Neuropsychopharmacology. 2015 Mar 13;40(5):1053-63. (PMID: 25409596)
Int Rev Neurobiol. 2021;160:223-250. (PMID: 34696874)
Mol Psychiatry. 2021 Sep;26(9):4719-4741. (PMID: 32555286)
Sci Adv. 2021 Aug 18;7(34):. (PMID: 34407947)
Neuroscience. 2008 Apr 22;153(1):259-67. (PMID: 18358631)
Alcohol Clin Exp Res. 2008 Feb;32(2):259-65. (PMID: 18162072)
Brain Sci. 2020 Dec 15;10(12):. (PMID: 33333877)
Alcohol Res. 2015;37(2):331-41, 344-51. (PMID: 26695754)
Alcohol Clin Exp Res. 2020 Oct;44(10):1933-1951. (PMID: 32997374)
Alcohol. 2019 Aug;78:57-68. (PMID: 30797833)
Alcohol Clin Exp Res. 2017 Nov;41(11):1886-1895. (PMID: 28833238)
J Neurosci. 2016 Aug 3;36(31):8050-63. (PMID: 27488625)
Front Behav Neurosci. 2017 Feb 22;11:29. (PMID: 28275340)
Pharmacol Biochem Behav. 2019 Jan;176:6-15. (PMID: 30419270)
Brain Res Mol Brain Res. 2004 Dec 20;132(2):146-54. (PMID: 15582154)
Neuropsychopharmacology. 2014 Jan;39(2):435-44. (PMID: 23966068)
Biol Psychiatry. 2021 Jun 15;89(12):1162-1175. (PMID: 33726937)
J Neurosci. 2002 Feb 1;22(3):1027-33. (PMID: 11826131)
Biol Psychiatry. 2007 Jan 1;61(1):78-86. (PMID: 16876134)
Neurobiol Stress. 2018 Dec 19;10:100143. (PMID: 30937349)
Alcohol Clin Exp Res. 2004 Apr;28(4):588-97. (PMID: 15100610)
Neuropharmacology. 2020 May 1;167:107984. (PMID: 32023486)
Pharmacol Rev. 2016 Jul;68(3):816-71. (PMID: 27363441)
Neuropsychopharmacology. 2019 Jan;44(1):166-183. (PMID: 29946108)
Brain Res. 1999 Nov 20;847(2):157-65. (PMID: 10575084)
Alcohol Clin Exp Res. 2000 Mar;24(3):361-5. (PMID: 10776677)
Neuropharmacology. 2016 Nov;110(Pt A):190-197. (PMID: 27450094)
PLoS One. 2018 Jan 9;13(1):e0190841. (PMID: 29315347)
Alcohol. 2016 Feb;50:73-82. (PMID: 26786746)
Neuropharmacology. 2017 Aug 1;122:100-106. (PMID: 28351600)
Neuroscience. 2017 Dec 26;367:159-168. (PMID: 29111360)
Alcohol Clin Exp Res. 2012 Feb;36(2):369-76. (PMID: 21895713)
Neuropsychopharmacology. 2014 Jan;39(2):283-90. (PMID: 23903031)
Nature. 2011 Feb 24;470(7335):492-7. (PMID: 21350482)
Handb Clin Neurol. 2021;179:403-418. (PMID: 34225978)
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2053-8. (PMID: 12566570)
Alcohol Clin Exp Res. 2017 Aug;41(8):1502-1509. (PMID: 28679148)
Eur J Neurosci. 2012 Apr;35(8):1368-80. (PMID: 22512261)
Lancet Psychiatry. 2016 Aug;3(8):760-773. (PMID: 27475769)
Brain Res. 1992 May 8;579(2):321-6. (PMID: 1352729)
Neuroscience. 2019 May 15;406:617-625. (PMID: 30790666)
Handb Clin Neurol. 2014;125:33-54. (PMID: 25307567)
JAMA. 2018 Aug 28;320(8):815-824. (PMID: 30167705)
J Pharmacol Exp Ther. 2013 Jul;346(1):130-7. (PMID: 23587526)
Int Rev Neurobiol. 2014;118:1-12. (PMID: 25175859)
Neuropsychopharmacology. 2014 Jun;39(7):1614-23. (PMID: 24434744)
Neuropharmacology. 2015 Feb;89:157-67. (PMID: 25229718)
Endocrinology. 2005 Apr;146(4):1650-73. (PMID: 15618360)
Neuropharmacology. 2011 Jul-Aug;61(1-2):35-42. (PMID: 21338616)
Nat Neurosci. 2015 Apr;18(4):545-52. (PMID: 25751534)
Biol Psychiatry. 2017 Jun 1;81(11):930-940. (PMID: 27113502)
Int J Neuropsychopharmacol. 2014 May;17(5):739-51. (PMID: 24345557)
Alcohol Clin Exp Res. 2020 Feb;44(2):553-566. (PMID: 31853996)
Front Cell Neurosci. 2016 Feb 23;10:45. (PMID: 26941607)
Alcohol Clin Exp Res. 2017 Dec;41(12):2066-2081. (PMID: 28941277)
J Neurosci. 2017 Feb 1;37(5):1139-1155. (PMID: 27986929)
Arch Gen Psychiatry. 2008 Apr;65(4):466-75. (PMID: 18391135)
J Headache Pain. 2018 Apr 4;19(1):28. (PMID: 29619773)
Mol Psychiatry. 1997 Jan;2(1):32-43. (PMID: 9154216)
Neuroscience. 2016 Oct 29;335:195-206. (PMID: 27578612)
Alcohol. 2021 Mar;91:21-27. (PMID: 33160072)
Front Neuroendocrinol. 2008 Jan;29(1):36-47. (PMID: 17904621)
Neurosci Biobehav Rev. 2014 Mar;40:1-5. (PMID: 24456941)
Biol Psychiatry. 1994 Sep 1;36(5):326-37. (PMID: 7993959)
Neuroscience. 2017 Mar 27;346:238-246. (PMID: 28131626)
Psychopharmacology (Berl). 2016 Apr;233(8):1435-43. (PMID: 26892380)

IK2 BX002488 United States BX BLRD VA; T32 AA007468 United States AA NIAAA NIH HHS; U01 AA013519 United States AA NIAAA NIH HHS; I01 BX004699 United States BX BLRD VA; P60 AA010760 United States AA NIAAA NIH HHS

Keywords: Alcohol; Chronic intermittent ethanol; Drinking-in-the-dark; Extended amygdala; Ventral striatum

0 (Receptors, Corticotropin-Releasing Hormone)
3K9958V90M (Ethanol)
9015-71-8 (Corticotropin-Releasing Hormone)

Date Created: 20220429 Date Completed: 20220519 Latest Revision: 20221123

20240105

PMC9677601

10.1016/j.neuropharm.2022.109074

35487273